HTX 0.00% 0.1¢ healthlinx limited

hard to validate biomarkers when the latest transvaginal...

  1. 23,765 Posts.
    lightbulb Created with Sketch. 258
    hard to validate biomarkers when the latest transvaginal ultrasound devices are getting far higher efficacy, still I guess this will be good in Africa where cheap detection will be most appropriate.
 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.